NCT07093190

Brief Summary

The goal of this interventional study is to observe the effects of bone marrow stem cell behavior in skeletal muscle of women between 60 to 75 years old after a single moderate resistance exercise session. Plant sterol Rg1, a compound known to enhance stem cell infiltration following exercise in young men will be tested against a placebo in a double blinded crossover design. The main questions to be answered are:

  • Does Rg1 supplementation alter serum sex hormone levels in recovery from exercise?
  • Does Rg1 supplementation influence bone marrow stem cell differentiation in skeletal muscles of older women? Participants will:
  • Pre-test body composition, maximal leg strength, blood and muscle tissue.
  • One hour after taking the supplement, participants will perform 4 sets of 10 repetitions of 70% of maximal strength (1RM) leg press and have two thigh muscle biopsies (0 and 24 h after exercise).
  • Repeat the protocol one month later on the alternative supplement. Researchers will understand whether Rg1 improves recovery response to resistance exercise in post-menopausal women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 18, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 2, 2022

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

July 21, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 30, 2025

Completed
Last Updated

July 30, 2025

Status Verified

July 1, 2025

Enrollment Period

9 months

First QC Date

July 21, 2025

Last Update Submit

July 21, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Stro-1+ bone marrow stem cell area in skeletal muscle biopsies

    Immunofluorescence staining will be used to semi-quantitatively analyze Stro-1+ BMSC presence in skeletal muscle of older women before, 0h and 24h after a moderate resistance exercise session.

    from enrolment to the end of study at 8 weeks

  • Nestin+ neural stem cell area in skeletal muscle biopsies

    Immunofluorescence staining will be used to semi-quantitatively analyze Nestin+ neural stem cell presence in skeletal muscle of older women before, 0h and 24h after a moderate resistance exercise session.

    from enrolment to the end of study at 8 weeks

  • CD34+/CD31+ vascular stem cell area in skeletal muscle biopsies

    Immunofluorescence staining will be used to semi-quantitatively analyzeCD34+/CD31+ vascular stem cell presence in skeletal muscle of older women before, 0h and 24h after a moderate resistance exercise session.

    from enrolment to the end of study at 8 weeks

  • Serum sex hormone levels 24 h following resistance exercise

    Forearm blood draw and Elisa analysis of serum for estradiol, progesterone, and testosterone of older women before and 24h after a moderate resistance exercise session.

    from enrolment to the end of study at 8 weeks

Study Arms (2)

exercise following Rg1 consumption

EXPERIMENTAL

1 hour following the consumption of the Rg1 supplement, participants performed exercise intervention before muscle biopsies were taken.

Dietary Supplement: exercise following Rg1 consumption

exercise only following placebo consumption

PLACEBO COMPARATOR

Crossover trial with placebo supplementation consumed before exercise

Dietary Supplement: Placebo

Interventions

The effect of Rg1 on exercised skeletal muscle in older women

exercise following Rg1 consumption
PlaceboDIETARY_SUPPLEMENT

Resistance exercise performed 1 hour following placebo consumption

exercise only following placebo consumption

Eligibility Criteria

Age60 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • sedentary, able to cease medications and supplements for 48 h before and 24 h after exercise session, medically sound for lower body moderate resistance exercise

You may not qualify if:

  • use of insulin, sex hormone and immune-modulating medications, smoking and regular alcohol consumption

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Taipei

Taipei, Taipei, 11153, Taiwan

Location

Related Publications (1)

  • Glaziou P, Martin PM. Study of factors that influence the clinical response to ciguatera fish poisoning. Toxicon. 1993 Sep;31(9):1151-4. doi: 10.1016/0041-0101(93)90130-b.

    PMID: 8266347BACKGROUND

Study Officials

  • Chia-hua Kuo, PhD

    University of Taipei

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 21, 2025

First Posted

July 30, 2025

Study Start

March 18, 2022

Primary Completion

December 2, 2022

Study Completion

July 1, 2025

Last Updated

July 30, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

The National Research Institutes of Health (Taiwan) will conduct gene analysis on remaining muscle samples for aiding understanding of sarcopenia

Locations